Table 3.
Description of ICU-acquired infection related to site of infection and microorganism (percentage of the total of pathogens isolated in a site)
| Pathogens | Pneumonia (n = 113) |
Bacteremia (n = 37) |
Catheter infection (n = 36) |
|---|---|---|---|
| Staphylococcus aureus | 21 (18.6) | 6 (16.2) | 3 (8.3) |
| Coagulase-negative Staphylococci | 8 (7.1) | 5 (13.5) | 9 (25.0) |
| Other GPB | 16 (14.2) | 9 (24.3) | 8 (22.2) |
| Fermenting GNP | 46 (40.7) | 13 (35.1) | 14 (38.9) |
| Non-fermenting GNP | 40 (35.4) | 6 (16.2) | 7 (19.4) |
| Anaerobes | 1 (0.9) | 1 (2.7) | 0 |
| Fungi | 5 (4.4) | 5 (13.5) | 1 (2.8) |
| Polymicrobial | 21 (18.6) | 8 (21.6) | 5 (13.9) |
| MDR pathogens | 47 (45.6) | 10 (27.0) | 9 (25.0) |
Data are expressed as number (%) or median [interquartile]. MDR: multi-drug-resistant, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae resistant to third-generation cephalosporins, Pseudomonas aeruginosa resistant to ticarcillin and/or imipenem and/or ceftazidime, Stenotrophomonas maltophilia, Burkholderia cepacia, and Acinetobacter baumannii. GPB; Gram-positive bacteria, GNB; Gram-negative Bacteria; non-fermenting GNB (Pseudomonas spp., Acinetobacter baumannii, Stenotrophomonas maltophilia, Burkholderia cepacia)